CN Stock MarketDetailed Quotes

300529 Jafron Biomedical

Watchlist
  • 28.93
  • +0.13+0.45%
Market Closed May 17 15:00 CST
23.36BMarket Cap44.51P/E (TTM)

Jafron Biomedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jafron Biomedical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

744.34M

+30.00%
EPS(YoY)

0.35

+45.63%
Analyst Rating

Strong Buy

May 17, 2024

Jafron Biomedical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/Q3473.838M / 554.000M--
--2023/Q2439.586M / 628.000M--
--2023/Q1572.558M / 632.000M--
--2021/Q1578.901M / 578.900M--
DatePeriodRevenue/EstimateEarnings Call
--2023/Q3473.838M / 554.000M--
--2023/Q2439.586M / 628.000M--
--2023/Q1572.558M / 632.000M--
--2021/Q1578.901M / 578.900M--

Jafron Biomedical Earnings Reports

  • Jafron Biomedical: 2023 Annual Report Summary

    Apr 25 11:00

  • Jafron Biomedical: 2024 First Quarter Report

    Apr 25 11:00

  • Jafron Biomedical: 2023 ANNUAL REPORT

    Apr 25 11:00

  • Jianfan Biotech: 2023 performance forecast

    Jan 19 03:14

    • Read more

    Analysis

    Analyst Rating

    Updated: May 17, 2024

    Strong Buy

    • Strong Buy

      77.78%

    • Buy

      22.22%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg